MabPlex
PrivateLast Round
Series B
Jun 8, 2020
Total Funding Raised
$129.8M
Company Overview
MabPlex is a biopharmaceutical company that provides comprehensive contract development and manufacturing services, ranging from drug development to the production of monoclonal antibodies, recombinant proteins, antibody-drug conjugates, and bispecifics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MabPlex Comps
Public and private peers based on sector, stage, and business model.
MabPlex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 8, 2020 | ||||
| Series A | Jan 29, 2019 |
MabPlex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Qiandao Fund | Series B |
| China Merchants Securities (HK) Co., Limited | Series B |
| National Fund for Technology Transfer and Commercialisation | Series A |
| China Merchants Securities | Series B |
| 德同资本 | Series B |
| OrbiMed | Series B |
| Huajin Capital | Series B |
MabPlex Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MabPlex's valuation, stock price, and market status.
